Evidence map›Paper›PMID 19750143›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2009

Injectable biomaterials for regenerating complex craniofacial tissues.

James D Kretlow, Simon Young, Leda Klouda, Mark Wong, Antonios G Mikos

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. [Advantages and prospects of cell derived decellularized extracellular matrix as tissue engineering scaffolds].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. A review of advanced hydrogels for cartilage tissue engineering.Frontiers in bioengineering and biotechnology · 2024
    Review
  15. Review
  16. Layered Double Hydroxides: A Novel Promising 2D Nanomaterial for Bone Diseases Treatment.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  17. Review
  18. Review
  19. Review
  20. Review

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

James D KretlowDepartment of Bioengineering, Rice University, Houston, TX 77251-1892, USA.
Simon Young
Leda Klouda
Mark Wong
Antonios G Mikos

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007330 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI PLON, SHARON E. · 1985 to 2019
$15.6M
BIOTECHNOLOGY RESEARCH TRAINING GRANTT32GM008362 · NIGMS · RICE UNIVERSITY · PI WEST, JENNIFER L · 1990 to 2010
$3.6M
In Situ Hardening Cellular Constructs for Craniofacial Bone RegenerationR01DE017441 · NIDCR · RICE UNIVERSITY · PI MIKOS, ANTONIOS G. · 2008 to 2012
$1.6M
NANOBIOLOGY INSTITUTIONAL TRAINING GRANT(RMI)T90DK070121 · NIDDK · UNIVERSITY OF HOUSTON · PI PETTITT, BERNARD MONTGOMERY · 2004 to 2008
$1.5M
PROMOTION OF ALVEOLAR SOCKET HEALING WITH BIOPOLYMERSR01DE015164 · NIDCR · RICE UNIVERSITY · PI MIKOS, ANTONIOS G. · 2004 to 2008
$1.4M
NIDCR NIH HHS R01 DE015164NIDCR NIH HHS R01 DE017441NIDDK NIH HHS T90 DK070121NIGMS NIH HHS T32 GM007330NIGMS NIH HHS T32 GM008362
6 · The paper itself

Abstract

Engineering complex tissues requires a precisely formulated combination of cells, spatiotemporally released bioactive factors, and a specialized scaffold support system. Injectable materials, particularly those delivered in aqueous solution, are considered ideal delivery vehicles for cells and bioactive factors and can also be delivered through minimally invasive methods and fill complex 3D shapes. In this review, we examine injectable materials that form scaffolds or networks capable of both replacing tissue function early after delivery and supporting tissue regeneration over a time period of weeks to months. The use of these materials for tissue engineering within the craniofacial complex is challenging but ideal as many highly specialized and functional tissues reside within a small volume in the craniofacial structures and the need for minimally invasive interventions is desirable due to aesthetic considerations. Current biomaterials and strategies used to treat craniofacial defects are examined, followed by a review of craniofacial tissue engineering, and finally an examination of current technologies used for injectable scaffold development and drug and cell delivery using these materials.

Indexed as

biomedical materialsdrug deliveryhydrogelspolymeric materialstissue engineering

Identifiers

PMID19750143
PMCPMC2742469

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.